Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Why it’s all about yield for Merchants Trust
The manager of Merchants Trust (MRCH), Simon Gergel, doesn’t share the widely-held view that dividend growth is more important than dividend yield.
As an example, let’s compare a hypothetical company offering a dividend yield of 8% but no dividend growth with another company offering a 2% dividend yield but growing the payout at 10% each year.
Gergel says it would take 15 years for the dividend payments from the low yield, high dividend growth company to exceed those of the high yielder.
He also argues high yielding stocks have generally outperformed lower yielders, citing a US study covering the 50 years from 1953 to 2003.
At Merchants Trust, Gergel targets stocks yielding at least in line with the market within 18 months.
Recognising that a high yield can be a signal for a dividend cut, yield alone is never seen as sufficient justification for buying a share and Merchants’ investments are not automatically sold if a yield drops below the market level.
HOW HAS THE TRUST PERFORMED?
Gergel’s approach underpins a dividend yield of 4.8% and the trust has a 36-year track record of raising dividends.
A recent addition to the portfolio which underlines the focus on yield is tobacco stock Imperial Brands (IMB). Although admitting to having some reservations about the tobacco industry, Gergel believes these are ‘now in the price’ on a price-to-earnings ratio of 10 and dividend yield of 7%.
He says the company enjoys significant barriers to entry and that tobacco is a resilient product. He sees the business as being well positioned in emerging vaping products.
On a sector basis, Gergel is positive on the opportunities in financial services, aerospace and defence firms and construction and materials, with limited exposure to ‘expensive defensives’. (TS)
Merchants Trust portfolio investment themes
Large core holdings in well financed global, ‘mega’ caps with strong franchises and good yields
Example: GlaxoSmithKline (GSK)
Exposure to emerging market consumer spending growth
Example: Informa (INF)
Inflation ‘tail risk’ – real assets, inflation-linked revenues attractive
Example: Greene King (GNK)
Recovery situations with industries recovering and companies on modest valuations
Example: Bovis Homes (BVS)
Financials for exposure to rising interest rates and volatility
Example: HSBC (HSBA)
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.